Nuclear Magnetic Resonance-Based Dissection of a Glycosyltransferase Specificity for the Mucin MUC1 Tandem Repeat

Richard D. Brokx, Leigh Revers, Qinghong Zhang, Shaoxian Yang, Tapas Mal, Mitsuhiko Ikura, Jean Gariépy

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The human glycoprotein MUC1 mucin plays a critical role in cancer progression. Breast, ovarian, and colon cancer cells often display unique cell-surface antigens corresponding to aberrantly glycosylated forms of the MUC1 tandem repeat. In this report, 15N- and 13C-labeled forms of a recombinant MUC1 construct containing five tandem repeats were used as substrates to define the order and kinetics of addition of N-acetylgalactosamine (GalNAc) moieties by a recombinant active form of the human enzyme UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase I (ppGalNAc-T1; residues 40-559). Heteronuclear NMR experiments were performed to assign resonances associated with the two serines (Ser5 and Ser15) and three threonines (Thr6, Thr14, and Thr19) present in the 20-residue long MUC1 repeat. The kinetics and order of addition of GalNAc moieties (Tn antigen) on the MUC1 construct by human ppGalNAc-T1 were subsequently dissected by NMR spectroscopy. Threonine 14 was shown to be rapidly glycosylated by ppGalNAc-T1 with an initial rate of 25 μM/min, followed by Thr6 (8.6 μM/min). The enzyme also modified Ser5 at a slower rate (1.7 μM/min), an event that started only after the glycosylation of Thr14 and Thr6 side chains was mostly completed. Ser15 and Thr19 remained unglycosyulated by ppGalNAc-T1. Corresponding O-glycosylation sites within all five tandem repeats were simultaneously modified by ppGalNAc-T1, suggesting that each repeat behaves as an independent substrate unit. This study demonstrated that the hydroxyl oxygens of Thr14 and to a lesser extent Thr 6 represent the two dominant substrates modified by ppGalNAc-T1 within the context of a complex MUC1 peptide substrate. More importantly, the availability of defined isotopically labelled MUC1 glycopeptide substrates and the relative simplicity of their NMR spectra will facilitate the analysis of other transferases within the O-glycosylation pathways and the rational design of tumor-associated MUC1 antigens.

Original languageEnglish (US)
Pages (from-to)13817-13825
Number of pages9
JournalBiochemistry
Volume42
Issue number47
DOIs
StatePublished - Dec 2 2003

Fingerprint

Dissection
Glycosyltransferases
Tandem Repeat Sequences
Mucins
Glycosylation
Magnetic Resonance Spectroscopy
Nuclear magnetic resonance
Threonine
Substrates
Biomolecular Nuclear Magnetic Resonance
Acetylgalactosamine
Glycopeptides
Enzymes
Surface Antigens
Transferases
Hydroxyl Radical
Ovarian Neoplasms
Colonic Neoplasms
Serine
Neoplasms

All Science Journal Classification (ASJC) codes

  • Biochemistry

Cite this

Brokx, Richard D. ; Revers, Leigh ; Zhang, Qinghong ; Yang, Shaoxian ; Mal, Tapas ; Ikura, Mitsuhiko ; Gariépy, Jean. / Nuclear Magnetic Resonance-Based Dissection of a Glycosyltransferase Specificity for the Mucin MUC1 Tandem Repeat. In: Biochemistry. 2003 ; Vol. 42, No. 47. pp. 13817-13825.
@article{5e6881d79fe24ea1b11b1a6bc33b1c09,
title = "Nuclear Magnetic Resonance-Based Dissection of a Glycosyltransferase Specificity for the Mucin MUC1 Tandem Repeat",
abstract = "The human glycoprotein MUC1 mucin plays a critical role in cancer progression. Breast, ovarian, and colon cancer cells often display unique cell-surface antigens corresponding to aberrantly glycosylated forms of the MUC1 tandem repeat. In this report, 15N- and 13C-labeled forms of a recombinant MUC1 construct containing five tandem repeats were used as substrates to define the order and kinetics of addition of N-acetylgalactosamine (GalNAc) moieties by a recombinant active form of the human enzyme UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase I (ppGalNAc-T1; residues 40-559). Heteronuclear NMR experiments were performed to assign resonances associated with the two serines (Ser5 and Ser15) and three threonines (Thr6, Thr14, and Thr19) present in the 20-residue long MUC1 repeat. The kinetics and order of addition of GalNAc moieties (Tn antigen) on the MUC1 construct by human ppGalNAc-T1 were subsequently dissected by NMR spectroscopy. Threonine 14 was shown to be rapidly glycosylated by ppGalNAc-T1 with an initial rate of 25 μM/min, followed by Thr6 (8.6 μM/min). The enzyme also modified Ser5 at a slower rate (1.7 μM/min), an event that started only after the glycosylation of Thr14 and Thr6 side chains was mostly completed. Ser15 and Thr19 remained unglycosyulated by ppGalNAc-T1. Corresponding O-glycosylation sites within all five tandem repeats were simultaneously modified by ppGalNAc-T1, suggesting that each repeat behaves as an independent substrate unit. This study demonstrated that the hydroxyl oxygens of Thr14 and to a lesser extent Thr 6 represent the two dominant substrates modified by ppGalNAc-T1 within the context of a complex MUC1 peptide substrate. More importantly, the availability of defined isotopically labelled MUC1 glycopeptide substrates and the relative simplicity of their NMR spectra will facilitate the analysis of other transferases within the O-glycosylation pathways and the rational design of tumor-associated MUC1 antigens.",
author = "Brokx, {Richard D.} and Leigh Revers and Qinghong Zhang and Shaoxian Yang and Tapas Mal and Mitsuhiko Ikura and Jean Gari{\'e}py",
year = "2003",
month = "12",
day = "2",
doi = "10.1021/bi0353070",
language = "English (US)",
volume = "42",
pages = "13817--13825",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "47",

}

Nuclear Magnetic Resonance-Based Dissection of a Glycosyltransferase Specificity for the Mucin MUC1 Tandem Repeat. / Brokx, Richard D.; Revers, Leigh; Zhang, Qinghong; Yang, Shaoxian; Mal, Tapas; Ikura, Mitsuhiko; Gariépy, Jean.

In: Biochemistry, Vol. 42, No. 47, 02.12.2003, p. 13817-13825.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Nuclear Magnetic Resonance-Based Dissection of a Glycosyltransferase Specificity for the Mucin MUC1 Tandem Repeat

AU - Brokx, Richard D.

AU - Revers, Leigh

AU - Zhang, Qinghong

AU - Yang, Shaoxian

AU - Mal, Tapas

AU - Ikura, Mitsuhiko

AU - Gariépy, Jean

PY - 2003/12/2

Y1 - 2003/12/2

N2 - The human glycoprotein MUC1 mucin plays a critical role in cancer progression. Breast, ovarian, and colon cancer cells often display unique cell-surface antigens corresponding to aberrantly glycosylated forms of the MUC1 tandem repeat. In this report, 15N- and 13C-labeled forms of a recombinant MUC1 construct containing five tandem repeats were used as substrates to define the order and kinetics of addition of N-acetylgalactosamine (GalNAc) moieties by a recombinant active form of the human enzyme UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase I (ppGalNAc-T1; residues 40-559). Heteronuclear NMR experiments were performed to assign resonances associated with the two serines (Ser5 and Ser15) and three threonines (Thr6, Thr14, and Thr19) present in the 20-residue long MUC1 repeat. The kinetics and order of addition of GalNAc moieties (Tn antigen) on the MUC1 construct by human ppGalNAc-T1 were subsequently dissected by NMR spectroscopy. Threonine 14 was shown to be rapidly glycosylated by ppGalNAc-T1 with an initial rate of 25 μM/min, followed by Thr6 (8.6 μM/min). The enzyme also modified Ser5 at a slower rate (1.7 μM/min), an event that started only after the glycosylation of Thr14 and Thr6 side chains was mostly completed. Ser15 and Thr19 remained unglycosyulated by ppGalNAc-T1. Corresponding O-glycosylation sites within all five tandem repeats were simultaneously modified by ppGalNAc-T1, suggesting that each repeat behaves as an independent substrate unit. This study demonstrated that the hydroxyl oxygens of Thr14 and to a lesser extent Thr 6 represent the two dominant substrates modified by ppGalNAc-T1 within the context of a complex MUC1 peptide substrate. More importantly, the availability of defined isotopically labelled MUC1 glycopeptide substrates and the relative simplicity of their NMR spectra will facilitate the analysis of other transferases within the O-glycosylation pathways and the rational design of tumor-associated MUC1 antigens.

AB - The human glycoprotein MUC1 mucin plays a critical role in cancer progression. Breast, ovarian, and colon cancer cells often display unique cell-surface antigens corresponding to aberrantly glycosylated forms of the MUC1 tandem repeat. In this report, 15N- and 13C-labeled forms of a recombinant MUC1 construct containing five tandem repeats were used as substrates to define the order and kinetics of addition of N-acetylgalactosamine (GalNAc) moieties by a recombinant active form of the human enzyme UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase I (ppGalNAc-T1; residues 40-559). Heteronuclear NMR experiments were performed to assign resonances associated with the two serines (Ser5 and Ser15) and three threonines (Thr6, Thr14, and Thr19) present in the 20-residue long MUC1 repeat. The kinetics and order of addition of GalNAc moieties (Tn antigen) on the MUC1 construct by human ppGalNAc-T1 were subsequently dissected by NMR spectroscopy. Threonine 14 was shown to be rapidly glycosylated by ppGalNAc-T1 with an initial rate of 25 μM/min, followed by Thr6 (8.6 μM/min). The enzyme also modified Ser5 at a slower rate (1.7 μM/min), an event that started only after the glycosylation of Thr14 and Thr6 side chains was mostly completed. Ser15 and Thr19 remained unglycosyulated by ppGalNAc-T1. Corresponding O-glycosylation sites within all five tandem repeats were simultaneously modified by ppGalNAc-T1, suggesting that each repeat behaves as an independent substrate unit. This study demonstrated that the hydroxyl oxygens of Thr14 and to a lesser extent Thr 6 represent the two dominant substrates modified by ppGalNAc-T1 within the context of a complex MUC1 peptide substrate. More importantly, the availability of defined isotopically labelled MUC1 glycopeptide substrates and the relative simplicity of their NMR spectra will facilitate the analysis of other transferases within the O-glycosylation pathways and the rational design of tumor-associated MUC1 antigens.

UR - http://www.scopus.com/inward/record.url?scp=0344844495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344844495&partnerID=8YFLogxK

U2 - 10.1021/bi0353070

DO - 10.1021/bi0353070

M3 - Article

C2 - 14636048

AN - SCOPUS:0344844495

VL - 42

SP - 13817

EP - 13825

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 47

ER -